Analysis of Memory Deficits Following Chemotherapy in Breast Cancer Survivors: Evidence from the Doors and People Test

REFERENCES

• Ahles , T. A. and Correa , D. D. 2010 . “ Neuropsychological impact of cancer and cancer treatments ” . In Psycho-Oncology , Edited by: Holland , J. C. , Breitbart , W. S. , Jacobsen , P. B. , Lederberg , M. S. , Loscalzo , M. J. and McCorkle , R. 251 – 257 . Oxford, UK, New York, NY : Oxford University Press .
   Google Scholar
• Ahles , T. A. , Saykin , A. J. , Furstenberg , C. T. , Cole , B. , Mott , L. A. , Skalla , K. and … Silberfarb , P. M. 2002 . Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma . Journal of Clinical Oncology , 20 ( 2 ) : 485 – 493 .
   PubMed Web of Science ®Google Scholar
• Anderson-Hanley , C. , Sherman , M. L. , Riggs , R. , Agocha , V. B. and Compas , B. E. 2003 . Neuropsychological effects of treatments for adults with cancer: a meta-analysis and review of the literature . Journal of the International Neuropsychological Society , 9 ( 7 ) : 967 – 982 .
   PubMed Web of Science ®Google Scholar
• Baddeley , A. , Emslie , H. and Nimmo-Smith , I. 1994 . TVTC Test—Doors and People , Retrieved from from http://www.tvtc.com/publications/TestProd.asp?TestID=15
   Google Scholar
• Bender , C. M. , Sereika , S. M. , Berga , S. L. , Vogel , V. G. , Brufsky , A. M. , Paraska , K. K. and Ryan , C. M. 2006 . Cognitive impairment associated with adjuvant therapy in breast cancer . Psychooncology , 15 ( 5 ) : 422 – 430 .
   PubMed Web of Science ®Google Scholar
• Bender , C. M. , Sereika , S. M. , Brufsky , A. M. , Ryan , C. M. , Vogel , V. G. , Rastogi , P. and …Berga , S. L. 2007 . Memory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancer . Menopause , 14 ( 6 ) : 995 – 998 .
   PubMedGoogle Scholar
• Burstein , H. U. J. , Prestrud , A. A. and Seidenfeld , J. 2010 . American Society of Clinical Oncology clinical practice guideline: Update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer . Journal of Clinical Oncology , 23 : 3784 – 3796 .
   Google Scholar
• Correa , D. D. and Ahles , T. A. 2007 . Cognitive adverse effects of chemotherapy in breast cancer patients . Current Opinions of Supportive and Palliative Care , 1 ( 1 ) : 57 – 62 .
   PubMedGoogle Scholar
• Debess , J. , Riis , J. O. , Engebjerg , M. C. and Ewertz , M. 2010 . Cognitive function after adjuvant treatment for early breast cancer: A population-based longitudinal study . Breast Cancer Research and Treatment , 121 ( 1 ) : 91 – 100 .
   PubMed Web of Science ®Google Scholar
• Donovan , K. A. , Small , B. J. , Andrykowski , M. A. , Schmitt , F. A. , Munster , P. and Jacobsen , P. B. 2005 . Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma . Cancer , 104 ( 11 ) : 2499 – 2507 .
   PubMed Web of Science ®Google Scholar
• Falleti , M. G. , Sanfilippo , A. , Maruff , P. , Weih , L. and Phillips , K. A. 2005 . The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: A meta-analysis of the current literature . Brain and Cognition , 59 ( 1 ) : 60 – 70 .
   PubMed Web of Science ®Google Scholar
• Harvey , J. M. , Clark , G. M. , Osborne , C. K. and Allred , D. C. 1999 . Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant therapy in breast cancer . Journal of Clinical Oncology , 17 : 1474 – 1481 .
   PubMed Web of Science ®Google Scholar
• Hunkin , N. M. , Stone , J. V. , Isaac , C. L. , Holdstock , J. S. , Butterfield , R. , Wallis , L. I. and Mayes , A. R. 2000 . Factor analysis of three standardized tests of memory in a clinical population . British Journal of Clinical Psychology , 39 ( Pt 2 ) : 169 – 180 .
   PubMedGoogle Scholar
• Iecovich , E. and Cwikel , J. 2010 . The relationship between well-being and self-rated health among middle-aged and older women in Israel . Clinical Gerontologist , 33 ( 4 ) : 259 – 269 .
   Google Scholar
• Inagaki , M. , Yoshikawa , E. , Matsuoka , Y. , Sugawara , Y. , Nakano , T. , Akechi , T. and …Uchitomi , Y. 2007 . Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy . Cancer , 109 ( 1 ) : 146 – 156 .
   PubMed Web of Science ®Google Scholar
• Ingraham , L. J. and Aiken , C. B. 1996 . An empirical approach to determining criteria for abnormality in test batteries with multiple measures . Neuropsychology , 10 : 120 – 124 .
   Web of Science ®Google Scholar
• Jenkins , V. , Shilling , V. , Deutsch , G. , Bloomfield , D. , Morris , R. , Allan , S. and …Winstanley , J. 2006 . A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer . British Journal of Cancer , 94 ( 6 ) : 828 – 834 .
   PubMed Web of Science ®Google Scholar
• Jenkins , V. , Shilling , V. , Fallowfield , L. , Howell , A. and Hutton , S. 2004 . Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study . Psychooncology , 13 ( 1 ) : 61 – 66 .
   PubMed Web of Science ®Google Scholar
• Manns , J. R. and Squire , L. R. 1999 . Impaired recognition memory on the Doors and People Test after damage limited to the hippocampal region . Hippocampus , 9 ( 5 ) : 495 – 499 .
   PubMedGoogle Scholar
• Mar Fan , H. G. , Clemons , M. , Xu , W. , Chemerynsky , I. , Breunis , H. , Braganza , S. and Tannock , I. F. 2008 . A randomised, placebo-controlled, double-blind trial of the effects of d-methylphenidate on fatigue and cognitive dysfunction in women undergoing adjuvant chemotherapy for breast cancer . Supportive Care in Cancer , 16 ( 6 ) : 577 – 583 .
   PubMedGoogle Scholar
• Mehlsen , M. , Pedersen , A. D. , Jensen , A. B. and Zachariae , R. 2009 . No indications of cognitive side-effects in a prospective study of breast cancer patients receiving adjuvant chemotherapy . Psychooncology , 18 ( 3 ) : 248 – 257 .
   PubMed Web of Science ®Google Scholar
• Mehnert , A. , Scherwath , A. , Schirmer , L. , Schleimer , B. , Petersen , C. , Schulz-Kindermann , F. and …Koch , U. 2007 . The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy . Patient Education and Counseling , 66 ( 1 ) : 108 – 118 .
   PubMed Web of Science ®Google Scholar
• Morris , R. and Abrahams , S. 1995 . Doors and People: Visual and verbal memory after unilateral temporal lobectomy . Neuropsychology , 9 ( 4 ) : 464 – 469 .
   Google Scholar
• Ribeiro , F. , de Mendonca , A. and Guerreiro , M. 2006 . Mild cognitive impairment: deficits in cognitive domains other than memory . Dementia and Geriatric Cognitive Disorders , 21 ( 5/6 ) : 284 – 290 .
   PubMedGoogle Scholar
• Saykin , A. J. , Ahles , T. A. and McDonald , B. C. 2003 . Mechanisms of chemotherapy-induced cognitive disorders: Neuropsychological, pathophysiological, and neuroimaging perspectives . Seminars in Clinical Neuropsychiatry , 8 ( 4 ) : 201 – 216 .
   PubMedGoogle Scholar
• Schagen , S. B. , Muller , M. J. , Boogerd , W. , Mellenbergh , G. J. and van Dam , F. S. 2006 . Change in cognitive function after chemotherapy: A prospective longitudinal study in breast cancer patients . Journal of the National Cancer Institute , 98 ( 23 ) : 1742 – 1745 .
   PubMedGoogle Scholar
• Schagen , S. B. , van Dam , F. S. , Muller , M. J. , Boogerd , W. , Lindeboom , J. and Bruning , P. F. 1999 . Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma . Cancer , 85 ( 3 ) : 640 – 650 .
   PubMed Web of Science ®Google Scholar
• Scherwath , A. , Mehnert , A. , Schleimer , B. , Schirmer , L. , Fehlauer , F. , Kreienberg , R. and …Koch , U. 2006 . Neuropsychological function in high-risk breast cancer survivors after stem-cell supported high-dose therapy versus standard-dose chemotherapy: Evaluation of long-term treatment effects . Annals of Oncology , 17 ( 3 ) : 415 – 423 .
   PubMed Web of Science ®Google Scholar
• Schilder , C. M. , Seynaeve , C. , Linn , S. C. , Boogerd , W. , Beex , L. V. , Gundy , C. M. and …Schagen , S. B. 2010 . Cognitive functioning of postmenopausal breast cancer patients before adjuvant systemic therapy, and its association with medical and psychological factors . Critical Reviews in Oncology/Hematology , 76 ( 2 ) : 133 – 141 .
   PubMedGoogle Scholar
• Silverman , D. H. , Dy , C. J. , Castellon , S. A. , Lai , J. , Pio , B. S. , Abraham , L. and …Ganz , P. A. 2007 . Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5–10 years after chemotherapy . Breast Cancer Research and Treatment , 103 ( 3 ) : 303 – 311 .
   PubMed Web of Science ®Google Scholar
• Tannock , I. F. , Ahles , T. A. , Ganz , P. A. and van Dam , F. S. 2004 . Cognitive impairment associated with chemotherapy for cancer: report of a workshop . Journal of Clinical Oncology , 22 ( 11 ) : 2233 – 2239 .
   PubMed Web of Science ®Google Scholar
• Tchen , N. , Juffs , H. G. , Downie , F. P. , Yi , Q. L. , Hu , H. , Chemerynsky , I. and …Tannock , I. F. 2003 . Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer . Journal of Clinical Oncology , 21 ( 22 ) : 4175 – 4183 .
   PubMed Web of Science ®Google Scholar
• van Dam , F. S. , Boogerd , W. , Schagen , S. B. , Muller , M. J. , Droogleever Fortuyn , M. E. , v.d. Wall , E. and Rodenhuis , S. 1998 . Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: High-dose versus standard-dose chemotherapy . Journal of National Cancer Institute , 90 ( 3 ) : 210 – 218 .
   PubMed Web of Science ®Google Scholar
• Vardy , J. , Rourke , S. and Tannock , I. F. 2007 . Evaluation of cognitive function associated with chemotherapy: A review of published studies and recommendations for future research . Journal of Clinical Oncology , 25 ( 17 ) : 2455 – 2463 .
   PubMed Web of Science ®Google Scholar
• Vardy , J. , Wong , K. , Yi , Q. L. , Park , A. , Maruff , P. and Wagner , L. 2006 . Assessing cognitive function in cancer patients . Supportive Care in Cancer , 14 ( 11 ) : 1111 – 1118 .
   PubMedGoogle Scholar
• Wefel , J. S. , Lenzi , R. , Theriault , R. , Buzdar , A. U. , Cruickshank , S. and Meyers , C. A. 2004 . ‘Chemobrain’ in breast carcinoma?: A prologue . Cancer , 101 ( 3 ) : 466 – 475 .
   PubMedGoogle Scholar
• Wefel , J. S. , Lenzi , R. , Theriault , R. L. , Davis , R. N. and Meyers , C. A. 2004 . The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: Results of a prospective, randomized, longitudinal trial . Cancer , 100 ( 11 ) : 2292 – 2299 .
   PubMed Web of Science ®Google Scholar